Form 4: Repligen Corp Executive Kuriyel Ralf Reports Stock Transactions
SEC Form 4 Filing
Senior VP of R&D at Repligen Corp, Ralf Kuriyel, reports the exercise of stock options and subsequent sale of shares.
Summary
- On March 11, 2024, Ralf Kuriyel, Senior VP of R&D at Repligen Corp, exercised stock options to acquire 1,271 shares of common stock at a price of $86.10.
- Following the exercise, Kuriyel sold 3,517 shares of common stock at a weighted average price of $193.73, with prices ranging from $193.64 to $194.06.
- After these transactions, Kuriyel directly owns 24,260 shares of Repligen Corp common stock.
- Kuriyel also holds options to purchase 0 shares of Repligen Corp common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the buying and selling activities of company executives. It's common for executives to exercise stock options and sell a portion of the acquired shares for personal financial management.
Key Dates
| Date | Description |
|---|---|
| 03/11/2024 | Date of stock option exercise and stock sale. |
| 03/12/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.